Glutarate

Glutarate

SCHEMBL106178

O=C([O-])CCCC(=O)O.[Na+]

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Glutarate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 known ✓ P00915 1/20 0.55
GABRP known ✓ O00591 1/20 0.46
GABRD known ✓ O14764 1/20 0.46
GABBR2 known ✓ O75899 1/20 0.46
THRB known ✓ P10828 1/20 0.46
GABRA1 known ✓ P14867 1/20 0.46
GABRB1 known ✓ P18505 1/20 0.46
GABRG2 known ✓ P18507 1/20 0.46
GABRB3 known ✓ P28472 1/20 0.46
GABRA5 known ✓ P31644 1/20 0.46
GABRA3 known ✓ P34903 1/20 0.46
GABRA2 known ✓ P47869 1/20 0.46
GABRB2 known ✓ P47870 1/20 0.46
GABRA4 known ✓ P48169 1/20 0.46
GABRE known ✓ P78334 1/20 0.46
GABRA6 known ✓ Q16445 1/20 0.46
GABRG1 known ✓ Q8N1C3 1/20 0.46
GABRG3 known ✓ Q99928 1/20 0.46
GABBR1 known ✓ Q9UBS5 1/20 0.46
GABRQ known ✓ Q9UN88 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutarate SCHEMBL106585 0.94 SLC22A6 (0.65) SLC22A6LMNACA1TSHRNFKB1
Glutarate SCHEMBL107714 0.94 SLC22A6 (0.65) SLC22A6LMNACA1TSHRNFKB1
Glutarate SCHEMBL16174471 0.94 SLC22A6 (0.65) SLC22A6LMNACA1TSHRNFKB1
Glutarate SCHEMBL31216427 0.94 SLC22A6 (0.65) SLC22A6LMNACA1TSHRNFKB1
Glutarate SCHEMBL30592618 0.94 SLC22A6 (0.65) SLC22A6LMNACA1TSHRNFKB1
Adipic Acid SCHEMBL21489542 0.94 LMNA (0.65) SLC22A6LMNACA1TSHRNFKB1
Adipic Acid SCHEMBL105756 0.94 LMNA (0.65) SLC22A6LMNACA1TSHRNFKB1
Glutarate SCHEMBL9930402 0.92 SLC22A6 (0.61) SLC22A6LMNACA1TSHRNFKB1
Pimelic Acid SCHEMBL30384892 0.92 TSHR (0.67) SLC22A6LMNACA1TSHRNFKB1
Sebacic Acid SCHEMBL6135890 0.92 TSHR (0.67) SLC22A6LMNACA1TSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2475000-B1 PROCESSING AGENT COMPOSITION FOR SEMICONDUCTOR SURFACE AND METHOD FOR PROCESSING SEMICONDUCTOR SURFACE USING SAME WAKO PURE CHEM IND LTD (JP) 2015-07-01 EP claimed
US-9034810-B2 Processing agent composition for semiconductor surface and method for processing semiconductor surface using same WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2015-05-19 US claimed
EP-2475000-A1 PROCESSING AGENT COMPOSITION FOR SEMICONDUCTOR SURFACE AND METHOD FOR PROCESSING SEMICONDUCTOR SURFACE USING SAME Wako Pure Chemical Industries, Ltd. (JP) 2012-07-11 EP claimed
US-20120157368-A1 PROCESSING AGENT COMPOSITION FOR SEMICONDUCTOR SURFACE AND METHOD FOR PROCESSING SEMICONDUCTOR SURFACE USING SAME WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2012-06-21 US claimed
EP-1312261-B1 Aqueous compositions containing a haloalkynyl compound and a buffer for providing biocidal activity and for stabilising end-use formulations TROY TECHNOLOGY CORP INC (US) 2006-08-30 EP claimed
EP-1312261-A1 Aqueous compositions containing a haloalkynyl compound and a buffer for providing biocidal activity and for stabilising end-use formulations Troy Technology Corporation, Inc. (US) 2003-05-21 EP claimed
EP-0831706-B1 NON-AQUEOUS COMPOSITIONS CONTAINING A HALOALKYNYL COMPOUND AND A BUFFER FOR PROVIDING BIOCIDAL ACTIVITY AND FOR STABILIZING END-USE FORMULATIONS TROY TECHNOLOGY CORP INC (US) 2003-05-02 EP claimed
US-6124350-A PAINT CONTAINING A BIOCIDAL COMPOSITION COMPRISING A HALOPROPYNYL COMPOUND AND A BUFFER TROY TECHNOLOGY CORPORATION, INC. (US) 2000-09-26 US claimed
US-6017955-A A BUFFER STABILIZER FOR ADJUSTING THE PH OF END-USE FORMULATION BETWEEN 3.0 AND 8.0 TO PREVENT DEGRADATION OF PESTICIDE 3-IODO-2-PROPYNYL BUTYL CARBAMATE TROY TECHNOLOGY CORPORATION, INC. (US) 2000-01-25 US claimed
EP-0831706-A1 METHOD OF STABILIZING BIOCIDAL COMPOSITIONS OF HALOALKYNYL COMPOUNDS TROY CHEMICAL CORPORATION (US) 1998-04-01 EP claimed
WO-1996039836-A1 METHOD OF STABILIZING BIOCIDAL COMPOSITIONS OF HALOALKYNYL COMPOUNDS TROY CHEMICAL COMPANY (US) 1996-12-19 WO claimed
US-5500668-A INK JET PRINTING XEROX CORPORATION (US) 1996-03-19 US claimed
CN-217585090-U Glutamic acid drying equipment 四川久邦食品有限公司 2022-10-14 CN disclosed
CN-112708645-A Method for efficiently producing monosodium glutamate 呼伦贝尔东北阜丰生物科技有限公司 2021-04-27 CN disclosed
CN-112006258-A Special-flavor powder chicken essence seasoning special for hot pot and preparation method thereof 重庆双鲜食品有限公司 2020-12-01 CN disclosed
CN-111903857-A Pig feed phagostimulant, preparation method and application method 长沙美日生物科技有限公司 2020-11-10 CN disclosed
EP-0275431-B1 NOVEL ANTHRACYCLINE DERIVATIVES, A PROCESS FOR PREPARING SAME AND THEIR USE AS MEDICAMENTS MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 1992-09-23 EP disclosed
EP-0275431-A1 Novel anthracycline derivatives, a process for preparing same and their use as medicaments MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 1988-07-27 EP disclosed
US-4401624-A CARBOXYLIC ACIDS AND METAL SALTS SYNTEX (U.S.A.) INC., 3401 HILLVIEW AVE., P.O. BPX 10850, PALO ALTO, CA. 94303, A CORP. OF DEL. 1983-08-30 US disclosed
US-4299822-A ANTITUMOR AGENTS SIDNEY FARBER CANCER INSTITUTE, INC. (US) 1981-11-10 US disclosed